Clinical evolution of patients with rheumatoid arthritis high and moderate activity treated bDMARDS, measure DAS28. Fundacion Investigación Médica del Atlantico
Evolución clínica de pacientes con artritis reumatoide con actividad alta y moderada tratados con bDMARDS, medida con DAS28. Fundación Investigación Médica del Atlántico
| dc.creator | Morales, Dayana | |
| dc.creator | Salas, José | |
| dc.creator | Pinedo, Jaime | |
| dc.date.accessioned | 2022-09-28T17:29:21Z | |
| dc.date.available | 2022-09-28T17:29:21Z | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3689603 | |
| dc.language | spa | |
| dc.publisher | Universidad Libre | |
| dc.relation | Revistas - Ciencias de la Salud | |
| dc.relation | https://revistas.unilibre.edu.co/index.php/biociencias/article/view/2633/2059 | |
| dc.relation | /*ref*/Aletaha D, Neogi T, Silman A, Funovits J, Felson DT, Bingham CO, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism. 2010; 62(9):2569- 81. | |
| dc.relation | /*ref*/Zeidler H. The need to better classify and diagnose early and very early rheumatoid arthritis. J Rheumatol. 2012; 39(2):212-7. | |
| dc.relation | /*ref*/Anaya JM, Pineda-Tamayo R, Gómez LM, Galarza Maldonado C, Rojas-Villaraga A, Martin J. Artritis reumatoide: bases moleculares, clínicas y terapéuticas. Medellín: CIB, Universidad del Rosario, FUNPAR; 2006. | |
| dc.relation | /*ref*/Cardiel, MH, Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol. 2002; 20(5):617-24. | |
| dc.relation | /*ref*/Weiss JE, Ilowite N. Juvenile Idiopatic Arthritis. Rheum Dis Clin Am. 2007; 33(4):441-70. | |
| dc.relation | /*ref*/Silman AJ, Hochberg MC. Epidemiology of the rheumatic diseases. 2nd ed. Oxford: Oxford University Press; 2001. | |
| dc.relation | /*ref*/Ravelli A and Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369(9563):767-78. | |
| dc.relation | /*ref*/Pugner KM, Scott DI, Holmes JW, Hieke K. The Cost of Rheumatoid Arthritis: An International Long-term View. Semin Arthritis Rheum. 2000; 29:305-20. | |
| dc.relation | /*ref*/Rueda J, González H, Abello-Banfi M. Evaluación y seguimiento de pacientes con artritis reumatoide. Colombia: Edimeco S A; 1998. | |
| dc.relation | /*ref*/Han C, Smolen J, Kavanaugh A, St.Clair EW, Baker D, Bala M. Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis. Arthritis Rheum. 2008; 59:510-4. | |
| dc.relation | /*ref*/Caballero C, Chalem P, Londoño J, Restrepo J, Iglesias A, Sánchez P, et al, Primer consenso colombiano sobre el tratamiento de la artritis reumatoide temprana. Revista Colombiana de Reumatología. 2002; 9(2):323-331. | |
| dc.relation | /*ref*/Callhoff J, Weib A, Zink A, and Listing J. Impact of biologic therapy on functional status in patients with rheumatoid arthritis-a metaanalysis. Rheumatology. 2013; 52:2127-35. | |
| dc.relation | /*ref*/Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic diseasemodifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008; 59:762-84. | |
| dc.relation | /*ref*/Neogi T, Aletaha D, Silman A, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis & Rheumatism. 2010; 62(9):2582-91. | |
| dc.relation | /*ref*/Singh JA, Noorbaloochi S, Singh G. Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010; 1:83-4. | |
| dc.relation | /*ref*/PRESERVE STUDY. Mantenimiento, reducción o retirada de etanercept después del tratamiento con etanercept y metotrexato en pacientes con artritis reumatoide moderada: ensayo controlado aleatorio. The Lancet. 2013; 381(9870):918-929. | |
| dc.relation | /*ref*/Anaya JM, Correa PA, Mantilla RD, ArcosBurgos M. Rheumatoid arthritis association in Colombian population is restricted to HLADRB1* 04 QRRAA alletes. Genes and Immunity. 2002; 3:56-8. | |
| dc.relation | /*ref*/Díaz J, Brenes F. Eficacia de los agentes antiTNFα en una cohorte de pacientes con artritis reumatoide en Costa Rica. Rev. Colomb. Reumatol. 2010; (17)4:205-11. | |
| dc.relation | /*ref*/Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005; 117:104-11. | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
| dc.rights | Atribución-NoComercial-SinDerivadas 2.5 Colombia | |
| dc.rights | Derechos de autor 2015 Biociencias | |
| dc.rights | https://creativecommons.org/licenses/by-sa/4.0/ | |
| dc.source | Biociencias; Vol 10 No 2 (2015): Biociencias; 11 - 19 | |
| dc.source | Biociencias; Vol. 10 Núm. 2 (2015): Biociencias; 11 - 19 | |
| dc.source | 2390-0512 | |
| dc.source | 0124-0110 | |
| dc.subject | Artritis reumatoide | |
| dc.subject | Evolución clínica | |
| dc.subject | Pacientes | |
| dc.title | Clinical evolution of patients with rheumatoid arthritis high and moderate activity treated bDMARDS, measure DAS28. Fundacion Investigación Médica del Atlantico | |
| dc.title | Evolución clínica de pacientes con artritis reumatoide con actividad alta y moderada tratados con bDMARDS, medida con DAS28. Fundación Investigación Médica del Atlántico |